An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shar...
VIENNA - An unnamed Novartis executive sold 925,400 Swiss francs worth of shares less than three weeks before the U.S. Food and Drug Administration announced data from tests of its gene therapy Zolgensma had been manipulated.
Novartis announced the stock sale by an executive member of the board of directors or a member of the executive committee in a Swiss stock exchange filing dated July 19. The sale was first reported by Swiss newspaper SonntagsZeitung on Sunday. The sale was made after the company had informed the FDA about the data manipulation but before the FDA announced it publically on Aug 6.The FDA said this month that Novartis notified regulators in June - more than a month after Zolgensma had been approved - that some of the early testing data had been manipulated.
Novartis said this month that it learned of allegations of data manipulation in mid-March and finished a preliminary investigation into the allegations in early May, confirming data discrepancies and raising data integrity concerns.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Novartis CEO Battles Fallout From Data ManipulationNovartis Chief Executive Vas Narasimhan has spent part of his 18 months at the helm of the drug giant cleaning up issues that emerged before his watch. Now, he is facing a storm of his own making.
Baca lebih lajut »
Rhianne Barreto is HBO's Latest Breakout StarThe British actress makes her film debut in the dark suburban drama 'Share.'
Baca lebih lajut »
Miley Cyrus releases emotional breakup song days after split from Liam HemsworthThe singer took to Twitter to share the track, Slide Away, about alcohol and drug abuse, after separating from husband Liam Hemsworth
Baca lebih lajut »
A New Dose of Hope in the Battle With Tuberculosis“If we play our cards right, extensively drug-resistant TB will be a thing of the past within 15 years,” says a researcher who helped develop a new therapy for the disease
Baca lebih lajut »
WeWork is going public: 5 things to know about the office-sharing companyOffice space-sharing company WeWork moved one step closer to the public markets on Wednesday, when it filed the paperwork for parent The We Company’s initial...
Baca lebih lajut »
How Harry and Meghan's Privacy Policies Are Breaking Royal Tradition, ApparentlyPrince Harry and Meghan Markle push for privacy, but the fact that they've taken titles and public funds makes that a break in tradition set by Princess Anne.
Baca lebih lajut »